BioNexus Gene Lab Corp. Payments to Acquire Equity Method Investments
BioNexus Gene Lab Corp. (BGLC) reported Payments to Acquire Equity Method Investments of $9.16 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-14.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireEquityMethodInvestments · last filed 2026-04-14
- BioNexus Gene Lab Corp. payments to acquire equity method investments for the quarter ending 2025-12-31 was $95.00, a 98.55% decline year-over-year.
- BioNexus Gene Lab Corp. payments to acquire equity method investments for the quarter ending 2024-12-31 was $6.56K.
- BioNexus Gene Lab Corp. payments to acquire equity method investments for the quarter ending 2024-09-30 was $221.40K.
- BioNexus Gene Lab Corp. payments to acquire equity method investments for fiscal 2025 was $9.16K, a 98.14% decline from fiscal 2024.
- BioNexus Gene Lab Corp. payments to acquire equity method investments for fiscal 2024 was $492.73K.
| Period end | Payments to Acquire Equity Method Investments 3 month | Payments to Acquire Equity Method Investments 6 month | Payments to Acquire Equity Method Investments 9 month | Payments to Acquire Equity Method Investments 12 month |
|---|---|---|---|---|
| 2025-12-31 | $95.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-14 | $9.16K 10-K · filed 2026-04-14 | ||
| 2025-09-30 | $9.06K 10-Q · filed 2025-11-14 | |||
| 2024-12-31 | $6.56K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-14 | $227.96K derived: sum of 2 quarters · filed 2026-04-14 | $492.73K 10-K · filed 2026-04-14 | |
| 2024-09-30 | $221.40K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $486.17K 10-Q · filed 2025-11-14 | ||
| 2024-06-30 | $264.77K 10-Q · filed 2025-08-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |